Evidence map›Paper›PMID 38379052›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2024

Disseminated nocardiosis and anti-GM-CSF antibodies.

Barbara Brugnoli, Lorenzo Salvati, Nicoletta Di Lauria, Annarita Botta, Camilla Tozzetti, Alessandro Biscarini, Manuela Capone, Filomena Ferrentino, Chiara Naldi, Giovanni Ascione and 11 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Barbara Brugnoli *Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Lorenzo Salvati *Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Nicoletta Di LauriaDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Annarita BottaDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Camilla TozzettiInternal Medicine Unit 3, Careggi University Hospital, Florence, Italy.
Alessandro BiscariniDepartment of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence-Careggi University Hospital, Florence, Italy.
Manuela CaponeDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Filomena FerrentinoInternal Medicine Unit 3, Careggi University Hospital, Florence, Italy.
Chiara NaldiInternal Medicine Unit 3, Careggi University Hospital, Florence, Italy.
Giovanni AscioneInternal Medicine Unit 3, Careggi University Hospital, Florence, Italy.
Alessio MazzoniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Laura MaggiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Ilaria CampoPneumology Unit, Internal Medicine and Infectious Diseases Department, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Brenna CareyTranslational Pulmonary Science Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Bruce TrapnellTranslational Pulmonary Science Center, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Francesco LiottaDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Lorenzo CosmiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Alessandro BartoloniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Francesco AnnunziatoDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Paola ParronchiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Boaz PaltererDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy. boaz.palterer@unifi.it.ORCID http://orcid.org/0000-0003-2499-8250

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections that are unusually severe or caused by opportunistic pathogens are a hallmark of primary immunodeficiency (PID). Anti-cytokine autoantibodies (ACA) are an emerging cause of acquired immunodeficiency mimicking PID. Nocardia spp. are Gram-positive bacteria generally inducing disseminated infections in immunocompromised patients, but seldom also occurring in apparently immunocompetent hosts. Anti-GM-CSF autoantibodies are associated with autoimmune pulmonary alveolar proteinosis (PAP). In those patients, an increased incidence of disseminated nocardiosis and cryptococcosis has been observed. It is unclear whether the PAP or the autoantibodies predispose to the infection. We report an apparently immunocompetent woman presenting with disseminated nocardiosis without any evidence of PAP. Clinical data and radiological images were retrospectively collected. Lymphocyte populations were analyzed by flow cytometry. Anti-GM-CSF autoantibodies were measured by ELISA. A 55-year-old otherwise healthy woman presented with cerebral and pulmonary abscesses. Personal and familial history of infections or autoimmunity were negative. After extensive examinations, a final diagnosis of disseminated nocardiosis was made. Immunologic investigations including neutrophilic function and IFN-γ/IL-12 circuitry failed to identify a PID. Whole-exome sequencing did not find pathogenic variants associated with immunodeficiency. Serum anti-GM-CSF autoantibodies were positive. There were no clinical or instrumental signs of PAP. Trimethoprim-sulfamethoxazole and imipenem were administered, with progressive improvement and recovery of the infectious complication. We identified anti-GM-CSF autoantibodies as the cause of disseminated nocardiosis in a previously healthy and apparently immunocompetent adult. This case emphasizes the importance of including ACA in the differential diagnosis of PID, especially in previously healthy adults. Importantly, anti-GM-CSF autoantibodies can present with disseminated nocardiosis without PAP.

Indexed as

AutoantibodiesGranulocyte-Macrophage Colony-Stimulating FactorNocardiaNocardia InfectionsFemaleHumansMiddle AgedAutoantibodiesGranulocyte-Macrophage Colony-Stimulating FactorAnti-cytokine autoantibodiesAnti-GM-CSF autoantibodiesImmunodeficiencyNocardiosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.